Cargando…

Controlled Drug Delivery Systems: Current Status and Future Directions

The drug delivery system enables the release of the active pharmaceutical ingredient to achieve a desired therapeutic response. Conventional drug delivery systems (tablets, capsules, syrups, ointments, etc.) suffer from poor bioavailability and fluctuations in plasma drug level and are unable to ach...

Descripción completa

Detalles Bibliográficos
Autores principales: Adepu, Shivakalyani, Ramakrishna, Seeram
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8512302/
https://www.ncbi.nlm.nih.gov/pubmed/34641447
http://dx.doi.org/10.3390/molecules26195905
_version_ 1784582958214021120
author Adepu, Shivakalyani
Ramakrishna, Seeram
author_facet Adepu, Shivakalyani
Ramakrishna, Seeram
author_sort Adepu, Shivakalyani
collection PubMed
description The drug delivery system enables the release of the active pharmaceutical ingredient to achieve a desired therapeutic response. Conventional drug delivery systems (tablets, capsules, syrups, ointments, etc.) suffer from poor bioavailability and fluctuations in plasma drug level and are unable to achieve sustained release. Without an efficient delivery mechanism, the whole therapeutic process can be rendered useless. Moreover, the drug has to be delivered at a specified controlled rate and at the target site as precisely as possible to achieve maximum efficacy and safety. Controlled drug delivery systems are developed to combat the problems associated with conventional drug delivery. There has been a tremendous evolution in controlled drug delivery systems from the past two decades ranging from macro scale and nano scale to intelligent targeted delivery. The initial part of this review provides a basic understanding of drug delivery systems with an emphasis on the pharmacokinetics of the drug. It also discusses the conventional drug delivery systems and their limitations. Further, controlled drug delivery systems are discussed in detail with the design considerations, classifications and drawings. In addition, nano-drug delivery, targeted and smart drug delivery using stimuli-responsive and intelligent biomaterials is discussed with recent key findings. The paper concludes with the challenges faced and future directions in controlled drug delivery.
format Online
Article
Text
id pubmed-8512302
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-85123022021-10-14 Controlled Drug Delivery Systems: Current Status and Future Directions Adepu, Shivakalyani Ramakrishna, Seeram Molecules Review The drug delivery system enables the release of the active pharmaceutical ingredient to achieve a desired therapeutic response. Conventional drug delivery systems (tablets, capsules, syrups, ointments, etc.) suffer from poor bioavailability and fluctuations in plasma drug level and are unable to achieve sustained release. Without an efficient delivery mechanism, the whole therapeutic process can be rendered useless. Moreover, the drug has to be delivered at a specified controlled rate and at the target site as precisely as possible to achieve maximum efficacy and safety. Controlled drug delivery systems are developed to combat the problems associated with conventional drug delivery. There has been a tremendous evolution in controlled drug delivery systems from the past two decades ranging from macro scale and nano scale to intelligent targeted delivery. The initial part of this review provides a basic understanding of drug delivery systems with an emphasis on the pharmacokinetics of the drug. It also discusses the conventional drug delivery systems and their limitations. Further, controlled drug delivery systems are discussed in detail with the design considerations, classifications and drawings. In addition, nano-drug delivery, targeted and smart drug delivery using stimuli-responsive and intelligent biomaterials is discussed with recent key findings. The paper concludes with the challenges faced and future directions in controlled drug delivery. MDPI 2021-09-29 /pmc/articles/PMC8512302/ /pubmed/34641447 http://dx.doi.org/10.3390/molecules26195905 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Review
Adepu, Shivakalyani
Ramakrishna, Seeram
Controlled Drug Delivery Systems: Current Status and Future Directions
title Controlled Drug Delivery Systems: Current Status and Future Directions
title_full Controlled Drug Delivery Systems: Current Status and Future Directions
title_fullStr Controlled Drug Delivery Systems: Current Status and Future Directions
title_full_unstemmed Controlled Drug Delivery Systems: Current Status and Future Directions
title_short Controlled Drug Delivery Systems: Current Status and Future Directions
title_sort controlled drug delivery systems: current status and future directions
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8512302/
https://www.ncbi.nlm.nih.gov/pubmed/34641447
http://dx.doi.org/10.3390/molecules26195905
work_keys_str_mv AT adepushivakalyani controlleddrugdeliverysystemscurrentstatusandfuturedirections
AT ramakrishnaseeram controlleddrugdeliverysystemscurrentstatusandfuturedirections